The Effect of Inflammatory Markers on Survival in Advanced Biliary Tract Carcinoma Treated with Gemcitabine/Oxaliplatin Regimen [0.03%]
炎症标志物对吉西他滨/奥沙利铂方案治疗晚期胆道癌患者生存影响的研究
Mahmut Buyuksimsek,Mehmet Mutlu Kidi,Ali Ogul et al.
Mahmut Buyuksimsek et al.
Background: In advanced biliary tract carcinoma (BTC), the prognosis is very poor, and the overall survival is less than 1 year. This study aimed to determine the effect of neutrophil-to-lymphocyte ratio (NLR), derived ne...
Hepatocellular Carcinoma in Paediatric Patients with Alagille Syndrome: Case Series and Review of Literature [0.03%]
儿童Alagille综合征肝细胞癌病例系列及文献回顾
Joseph J Valamparampil,Naresh Shanmugam,Mukul Vij et al.
Joseph J Valamparampil et al.
Benefits of the 8th American Joint Committee on Cancer System for Hepatocellular Carcinoma Staging [0.03%]
美国第8版癌症联合委员会肝细胞癌分期的利点分析
Catalin Bogdan Satala,Ioan Jung,Laszlo Kobori et al.
Catalin Bogdan Satala et al.
Purpose: We aimed to emphasize the prognostic impact of differences included in the 8th versus the previous 7th edition of AJCC (American Joint Committee on Cancer) Cancer Staging manual for hepatocellular carcinoma (HCC)...
Angiopoietin-2 as a Prognostic Factor in Patients with Incurable Stage IV Colorectal Cancer [0.03%]
angiopoietin-2在晚期不可治愈性结直肠癌患者中的预后价值
Shinya Munakata,Takae Ueyama,Haruna Ishihara et al.
Shinya Munakata et al.
Purpose: Angiopoietin (Ang), a ligand of the endothelium-specific receptor Tie-2 system, is associated with tumor growth and progression that depend on angiogenesis. The present study aimed to investigate the predictive p...
Bobak Moazzami,Keivan Majidzadeh-A,Arash Dooghaie-Moghadam et al.
Bobak Moazzami et al.
Background: Cholangiocarcinoma (CCA) is the second most frequent primary liver tumor and defined as the heterogeneous group of tumors derived from cells in the biliary tree. ...
Colorectal Cancer Trends of 2018 in Romania-an Important Geographical Variation Between Northern and Southern Lands and High Mortality Versus European Averages [0.03%]
2018年罗马尼亚结直肠癌流行病学特点及欧洲平均死亡率的地域差异
Elena Mirela Ionescu,Cristian George Tieranu,Dana Maftei et al.
Elena Mirela Ionescu et al.
Purpose: In Romania, one of the highest rates for colorectal cancer (CRC) incidence and mortality in Europe was estimated based on data available in 2008. Ever since, consistent data are missing. In this article, we tried...
Comparative Study
Journal of gastrointestinal cancer. 2021 Mar;52(1):222-228. DOI:10.1007/s12029-020-00382-3 2021
Optimal Radiotherapy Dose in Anal Cancer: Trends in Prescription Dose and Association with Survival [0.03%]
直肠癌的最优放疗剂量：处方剂量趋势及与生存率的关系
Nishant K Shah,Muhammad M Qureshi,Michael A Dyer et al.
Nishant K Shah et al.
Purpose: Definitive chemoradiotherapy represents a standard of care treatment for localized anal cancer. National Comprehensive Cancer Network guidelines recommend radiotherapy (RT) doses of ≥ 45 Gy and escalation to 50....
Vivek Sukumar,Shraddha Patkar,Mahesh Goel et al.
Vivek Sukumar et al.
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome [0.03%]
telotristat乙酸酯治疗类癌综合征腹泻症状持续改善的起始时间:III期临床试验分析
Joseph S Dillon,Matthew H Kulke,Dieter Hörsch et al.
Joseph S Dillon et al.
Background: Telotristat ethyl is approved to treat carcinoid syndrome diarrhea in combination with somatostatin analogs. In TELESTAR and TELECAST phase III studies, patients with carcinoid syndrome received telotristat et...
Naveen Padmanabhan,Ann Kurian,Aasim Hussain et al.
Naveen Padmanabhan et al.